Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation. / Hernández-Alonso, Pablo; García-Gavilán, Jesús; Camacho-Barcia, Lucía; Sjödin, Anders Mikael; Hansen, Thea Toft; Harrold, Jo; Salas-Salvadó, Jordi; Halford, Jason C G; Canudas, Silvia; Bulló, Mònica.

I: Scientific Reports, Bind 9, 13895, 2019.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Hernández-Alonso, P, García-Gavilán, J, Camacho-Barcia, L, Sjödin, AM, Hansen, TT, Harrold, J, Salas-Salvadó, J, Halford, JCG, Canudas, S & Bulló, M 2019, 'Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation', Scientific Reports, bind 9, 13895. https://doi.org/10.1038/s41598-019-50260-7

APA

Hernández-Alonso, P., García-Gavilán, J., Camacho-Barcia, L., Sjödin, A. M., Hansen, T. T., Harrold, J., Salas-Salvadó, J., Halford, J. C. G., Canudas, S., & Bulló, M. (2019). Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation. Scientific Reports, 9, [13895]. https://doi.org/10.1038/s41598-019-50260-7

Vancouver

Hernández-Alonso P, García-Gavilán J, Camacho-Barcia L, Sjödin AM, Hansen TT, Harrold J o.a. Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation. Scientific Reports. 2019;9. 13895. https://doi.org/10.1038/s41598-019-50260-7

Author

Hernández-Alonso, Pablo ; García-Gavilán, Jesús ; Camacho-Barcia, Lucía ; Sjödin, Anders Mikael ; Hansen, Thea Toft ; Harrold, Jo ; Salas-Salvadó, Jordi ; Halford, Jason C G ; Canudas, Silvia ; Bulló, Mònica. / Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation. I: Scientific Reports. 2019 ; Bind 9.

Bibtex

@article{a467b1da31364d6cbe7f55bf04a7ab7f,
title = "Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation",
abstract = "Different plasma metabolites have been related to insulin resistance (IR). However, there is a lack of metabolite models predicting IR with external validation. The aim of this study is to identify a multi-metabolite model associated to the homeostatic model assessment (HOMA)-IR values. We performed a cross-sectional metabolomics analysis of samples collected from overweight and obese subjects from two independent studies. The training step was performed in 236 subjects from the SATIN study and validated in 102 subjects from the GLYNDIET study. Plasma metabolomics profile was analyzed using three different approaches: GC/quadrupole-TOF, LC/quadrupole-TOF, and nuclear magnetic resonance (NMR). Associations between metabolites and HOMA-IR were assessed using elastic net regression analysis with a leave-one-out cross validation (CV) and 100 CV runs. HOMA-IR was analyzed both as linear and categorical (median or lower versus higher than the median). Receiver operating characteristic curves were constructed based on metabolites' weighted models. A set of 30 metabolites discriminating extremes of HOMA-IR were consistently selected. These metabolites comprised some amino acids, lipid species and different organic acids. The area under the curve (AUC) for the discrimination between HOMA-IR extreme categories was 0.82 (95% CI: 0.74-0.90), based on the multi-metabolite model weighted with the regression coefficients of metabolites in the validation dataset. We identified a set of metabolites discriminating between extremes of HOMA-IR and able to predict HOMA-IR with high accuracy.",
author = "Pablo Hern{\'a}ndez-Alonso and Jes{\'u}s Garc{\'i}a-Gavil{\'a}n and Luc{\'i}a Camacho-Barcia and Sj{\"o}din, {Anders Mikael} and Hansen, {Thea Toft} and Jo Harrold and Jordi Salas-Salvad{\'o} and Halford, {Jason C G} and Silvia Canudas and M{\`o}nica Bull{\'o}",
note = "CURIS 2019 NEXS 322",
year = "2019",
doi = "10.1038/s41598-019-50260-7",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation

AU - Hernández-Alonso, Pablo

AU - García-Gavilán, Jesús

AU - Camacho-Barcia, Lucía

AU - Sjödin, Anders Mikael

AU - Hansen, Thea Toft

AU - Harrold, Jo

AU - Salas-Salvadó, Jordi

AU - Halford, Jason C G

AU - Canudas, Silvia

AU - Bulló, Mònica

N1 - CURIS 2019 NEXS 322

PY - 2019

Y1 - 2019

N2 - Different plasma metabolites have been related to insulin resistance (IR). However, there is a lack of metabolite models predicting IR with external validation. The aim of this study is to identify a multi-metabolite model associated to the homeostatic model assessment (HOMA)-IR values. We performed a cross-sectional metabolomics analysis of samples collected from overweight and obese subjects from two independent studies. The training step was performed in 236 subjects from the SATIN study and validated in 102 subjects from the GLYNDIET study. Plasma metabolomics profile was analyzed using three different approaches: GC/quadrupole-TOF, LC/quadrupole-TOF, and nuclear magnetic resonance (NMR). Associations between metabolites and HOMA-IR were assessed using elastic net regression analysis with a leave-one-out cross validation (CV) and 100 CV runs. HOMA-IR was analyzed both as linear and categorical (median or lower versus higher than the median). Receiver operating characteristic curves were constructed based on metabolites' weighted models. A set of 30 metabolites discriminating extremes of HOMA-IR were consistently selected. These metabolites comprised some amino acids, lipid species and different organic acids. The area under the curve (AUC) for the discrimination between HOMA-IR extreme categories was 0.82 (95% CI: 0.74-0.90), based on the multi-metabolite model weighted with the regression coefficients of metabolites in the validation dataset. We identified a set of metabolites discriminating between extremes of HOMA-IR and able to predict HOMA-IR with high accuracy.

AB - Different plasma metabolites have been related to insulin resistance (IR). However, there is a lack of metabolite models predicting IR with external validation. The aim of this study is to identify a multi-metabolite model associated to the homeostatic model assessment (HOMA)-IR values. We performed a cross-sectional metabolomics analysis of samples collected from overweight and obese subjects from two independent studies. The training step was performed in 236 subjects from the SATIN study and validated in 102 subjects from the GLYNDIET study. Plasma metabolomics profile was analyzed using three different approaches: GC/quadrupole-TOF, LC/quadrupole-TOF, and nuclear magnetic resonance (NMR). Associations between metabolites and HOMA-IR were assessed using elastic net regression analysis with a leave-one-out cross validation (CV) and 100 CV runs. HOMA-IR was analyzed both as linear and categorical (median or lower versus higher than the median). Receiver operating characteristic curves were constructed based on metabolites' weighted models. A set of 30 metabolites discriminating extremes of HOMA-IR were consistently selected. These metabolites comprised some amino acids, lipid species and different organic acids. The area under the curve (AUC) for the discrimination between HOMA-IR extreme categories was 0.82 (95% CI: 0.74-0.90), based on the multi-metabolite model weighted with the regression coefficients of metabolites in the validation dataset. We identified a set of metabolites discriminating between extremes of HOMA-IR and able to predict HOMA-IR with high accuracy.

U2 - 10.1038/s41598-019-50260-7

DO - 10.1038/s41598-019-50260-7

M3 - Journal article

C2 - 31554919

AN - SCOPUS:85072676565

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 13895

ER -

ID: 228361654